NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 1 filers reported holding NEWLINK GENETICS CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2019 | $116,000 | +73.1% | 42,087 | 0.0% | 0.01% | +125.0% |
| Q3 2019 | $67,000 | +26.4% | 42,087 | +54.5% | 0.00% | -42.9% |
| Q1 2019 | $53,000 | +1666.7% | 27,247 | +1846.2% | 0.01% | – |
| Q3 2018 | $3,000 | -40.0% | 1,400 | +40.0% | 0.00% | – |
| Q2 2018 | $5,000 | +25.0% | 1,000 | +100.0% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -92.5% | 500 | -98.2% | 0.00% | -100.0% |
| Q1 2016 | $53,000 | – | 27,247 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |